What is the current stock price of Immage Biotherapeutics Corp. (IMMG)?

As of the latest market data, Immage Biotherapeutics Corp. (IMMG) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does Immage Biotherapeutics Corp. (IMMG) pay a dividend?

Based on current data, Immage Biotherapeutics Corp. does not have a confirmed active dividend policy.

What is the market cap of Immage Biotherapeutics Corp.?

The current market capitalization of Immage Biotherapeutics Corp. (IMMG) is approximately unavailable.

IMMG

Immage Biotherapeutics Corp.·Financial Services

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.

Sector

Financial Services

Industry

Financial - Conglomerates

Employees

IPO Date

2022-12-02

Beta

32.51

Websitewww.immagebio.com↗